S. Herrero Bermejo, E. Lobato Matilla, D. Gómez Costas, B. Somoza Fernández, P. Ruíz Briones, M. Ferris Villanueva, Mdp Montero Antón, Y. Rioja Díez, A. Carrillo Burdallo, A. Herranz Alonso, M. Sanjurjo Sáez
{"title":"4CPS-193 对皮下注射疗法失去反应或部分反应的克罗恩病患者加强静脉注射乌斯特库单抗的有效性和安全性","authors":"S. Herrero Bermejo, E. Lobato Matilla, D. Gómez Costas, B. Somoza Fernández, P. Ruíz Briones, M. Ferris Villanueva, Mdp Montero Antón, Y. Rioja Díez, A. Carrillo Burdallo, A. Herranz Alonso, M. Sanjurjo Sáez","doi":"10.1136/ejhpharm-2024-eahp.297","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":121840,"journal":{"name":"Section 4: Clinical pharmacy services","volume":"38 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy\",\"authors\":\"S. Herrero Bermejo, E. Lobato Matilla, D. Gómez Costas, B. Somoza Fernández, P. Ruíz Briones, M. Ferris Villanueva, Mdp Montero Antón, Y. Rioja Díez, A. Carrillo Burdallo, A. Herranz Alonso, M. Sanjurjo Sáez\",\"doi\":\"10.1136/ejhpharm-2024-eahp.297\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":121840,\"journal\":{\"name\":\"Section 4: Clinical pharmacy services\",\"volume\":\"38 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Section 4: Clinical pharmacy services\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/ejhpharm-2024-eahp.297\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Section 4: Clinical pharmacy services","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/ejhpharm-2024-eahp.297","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
4CPS-193 Effectiveness and safety of intravenous ustekinumab intensification in Crohn’s disease with loss of response or partial response to subcutaneous therapy